Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Shares of NASDAQ:ATHX opened at $0.01 on Monday. Athersys has a 1-year low of $0.01 and a 1-year high of $1.99. The firm has a market cap of $833,206.50, a price-to-earnings ratio of -0.01 and a beta of -0.90.
About Athersys
Read More
- Five stocks we like better than Athersys
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
